Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

844
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
844
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

766
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
766
Pulse rhythm01:30

Pulse rhythm

1.3K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective.

Diabetes & metabolism journal·2026
Same author

Engaging Stakeholders to Define Research Priorities and Build a Research Community to Reduce Obesity Among Hispanic Women in the Southeastern United States.

Journal of racial and ethnic health disparities·2026
Same author

Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance.

Circulation. Population health and outcomes·2026
Same author

Foods to Prevent Cardiometabolic Disease: Moving from "Saturated Fat" to "Whole Foods".

Current developments in nutrition·2026
Same author

Challenges of using AI-based synthetic data in health economics and outcomes research.

Expert review of pharmacoeconomics & outcomes research·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026

関連する実験動画

Updated: Jan 8, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

7.5K

2型糖尿病患者にとって重要な持続血糖測定の属性

Tim C Lai1, Heather P Whitley2, Mesfin Genie3,4

  • 1Department of Health Outcomes Research and Policy, Auburn University Harrison College of Pharmacy, Auburn, AL.

Clinical diabetes : a publication of the American Diabetes Association
|December 24, 2025
PubMed
まとめ

2型糖尿病患者にとって、自己負担費用と精度は持続血糖測定（CGM）システムを選択する際の重要な要因です。受信機画面情報はそれほど重要ではありませんが、その解釈に関する教育はCGMの利点を改善する可能性があります。

キーワード:
持続血糖測定2型糖尿病患者の選択費用精度アドヒアランス教育

さらに関連する動画

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.2K

関連する実験動画

Last Updated: Jan 8, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

7.5K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.2K

科学分野:

  • 内分泌学
  • 医療機器
  • 患者報告アウトカム

背景:

  • 持続血糖測定（CGM）は、2型糖尿病の管理に不可欠です。
  • 患者の好みは、糖尿病技術の採用とアドヒアランスに大きく影響します。
  • CGMシステムの重要な意思決定要因を理解することは、効果的な患者ケアに不可欠です。

研究 の 目的:

  • 持続血糖測定（CGM）システムの患者選択に影響を与える最も重要な属性を特定すること。
  • CGMシステム選択における受信機画面情報の役割を探求すること。
  • 患者と医療提供者のコミュニケーションとCGMアドヒアランスを改善するための戦略を知らせること。

主な方法:

  • 2型糖尿病患者のCGM属性に対する患者の好みを評価するアンケートベースの研究。
  • 2型糖尿病患者における属性重要度評価の分析。
  • CGMシステム選択に影響を与える要因の定性的または定量的評価。

主要な成果:

  • 自己負担費用とシステム精度がCGM選択の主な要因として特定されました。
  • 受信機画面情報は、CGMシステム選択において患者によって重要でないと意外に判断されました。
  • CGMシステムに対する患者の好みは異質ですが、コストと精度が中心です。

結論:

  • 患者教育とシステム設計においてコストと精度に焦点を当てることで、2型糖尿病のCGM採用を強化できます。
  • CGM受信機画面データの患者理解を改善することで、技術の全体的な有用性と利点を高めることができます。
  • 糖尿病管理とアドヒアランスを最適化するには、患者の優先順位に合わせてCGMシステムを調整することが不可欠です。